About the Authors

Antonello Pessi

a.pessi@peptipharma.it (AP); map2028@med.cornell.edu (MP)

Affiliation PeptiPharma, Pomezia, Rome, Italy

Annunziata Langella

Affiliation Merck Serono, Guidonia Montecelio, Rome, Italy

Elena Capitò

Affiliation BASF Italia, Pontecchio Marconi, Bologna, Italy

Silvia Ghezzi

Affiliation Viral Pathogens and Biosafety, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy

Elisa Vicenzi

Affiliation Viral Pathogens and Biosafety, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy

Guido Poli

Affiliations AIDS Immunopathogenesis Units, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy, Vita-Salute San Raffaele University, School of Medicine, Milan, Italy

Thomas Ketas

Affiliation Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America

Cyrille Mathieu

Affiliations INSERM, Ecole Normale Supérieure de Lyon, Lyon, France, Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America

Riccardo Cortese

Affiliation CEINGE, Naples, Italy

Branka Horvat

Affiliations INSERM, Ecole Normale Supérieure de Lyon, Lyon, France, IFR128 BioSciences Lyon-Gerland Lyon-Sud, University of Lyon, Lyon, France

Anne Moscona

Affiliations Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America, Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America

Matteo Porotto

a.pessi@peptipharma.it (AP); map2028@med.cornell.edu (MP)

Affiliation Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America

Competing Interests

The authors have read the journal's policy and have the following conflicts: Antonello Pessi is the owner of a small company (PeptiPharma) and the holder of the intellectual properties for the cholesterol addition and the dimerization of peptides. Annunziata Langella is currently an employe at Merck Serono and, Elena Capitò is currently an employe at BASF Italy. They do not hold any intellectual properties regarding the cholesterol tagged peptides and do not have any other competing interest. Anne Moscona and Matteo Porotto receive funds from NIH to study the antiviral properties of the fusion inhibitor peptides. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: AP MP AM BH RC. Performed the experiments: AL EC MP SG TK CM. Analyzed the data: AP MP AM BH TK CM. Wrote the paper: AP AM MP BH EV GP.